Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.

European journal of medical research - 18 Aug 2000

Kasten S, Goldwich A, Schmitt M, Rascu A, Grunke M, Dechant C, Kalden J R, Harrer T

Abstract excerpt

The heterozygous 32 base pair deletion of the chemokine receptor 5 (Delta32CCR5) has been associated with a more benign course of HIV-1-infection. To study the influence of Delta32CCR5 on the response to antiviral therapy we analyzed the presence of Delta32CCR5 by PCR in PBMC from 107 randomly selected HIV-1-infected patients treated with HAART for at least three months. 24 of 107 patients were heterozygous for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dideoxynucleosides

Share to Drug Resistance, Microbial

Share to Lamivudine

Share to Receptors, CCR5

Share to Zidovudine

Source

Identifiers

PMID: 10958764

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.PMID 10958764Read ↗

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.Semantic proximity Read ↗

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.Semantic proximity Read ↗

Association between CCR5 genotype and the clinical course of HIV-1 infection.Semantic proximity Read ↗

HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.Semantic proximity Read ↗

HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.Semantic proximity Read ↗

Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?Semantic proximity Read ↗

The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin.Semantic proximity Read ↗

Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.Semantic proximity Read ↗

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.Semantic proximity Read ↗

CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status.Semantic proximity Read ↗

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.Semantic proximity Read ↗

Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech RepublicSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.